Green Lifescience Co., Ltd. (KOSDAQ: 114450)
South Korea
· Delayed Price · Currency is KRW 1,683.00
-68.00 (-3.88%)
Dec 20, 2024, 1:52 PM KST
Green Lifescience Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 21,587 | 22,369 | 36,505 | 25,338 | 24,561 | 37,618 | Upgrade
|
| Other Revenue | 0 | 0 | 0 | 0 | - | -0 | Upgrade
|
| Revenue | 21,587 | 22,369 | 36,505 | 25,338 | 24,561 | 37,618 | Upgrade
|
| Revenue Growth (YoY) | -6.67% | -38.72% | 44.07% | 3.16% | -34.71% | 14.85% | Upgrade
|
| Cost of Revenue | 20,115 | 24,683 | 37,861 | 27,608 | 24,635 | 34,586 | Upgrade
|
| Gross Profit | 1,472 | -2,313 | -1,356 | -2,270 | -74.77 | 3,032 | Upgrade
|
| Selling, General & Admin | 1,930 | 1,996 | 2,027 | 2,085 | 1,736 | 2,180 | Upgrade
|
| Research & Development | 359.14 | 112.11 | 425.82 | 109.59 | - | - | Upgrade
|
| Other Operating Expenses | 12.16 | 3.08 | 7.57 | 0.53 | 0.54 | 7.4 | Upgrade
|
| Operating Expenses | 2,500 | 2,330 | 2,602 | 2,378 | 1,834 | 2,441 | Upgrade
|
| Operating Income | -1,029 | -4,643 | -3,958 | -4,648 | -1,909 | 591.1 | Upgrade
|
| Interest Expense | -208.51 | -240.43 | -113.34 | -22.2 | -18.87 | -22.46 | Upgrade
|
| Interest & Investment Income | 504.68 | 697.58 | 626.6 | 674.92 | 554.94 | 695.13 | Upgrade
|
| Currency Exchange Gain (Loss) | -210.07 | -55.15 | -5.29 | -18.17 | -34.79 | -44.18 | Upgrade
|
| Other Non Operating Income (Expenses) | 132.41 | -65.72 | -106.51 | 181.34 | -100.49 | 26.11 | Upgrade
|
| EBT Excluding Unusual Items | -810.15 | -4,307 | -3,557 | -3,832 | -1,508 | 1,246 | Upgrade
|
| Gain (Loss) on Sale of Investments | 241 | 43.71 | 694.8 | 416.74 | 636.86 | 82.79 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 1.39 | -2.24 | - | 11.44 | Upgrade
|
| Asset Writedown | -12,095 | -12,095 | - | - | - | - | Upgrade
|
| Pretax Income | -12,664 | -16,358 | -2,860 | -3,418 | -871.4 | 1,340 | Upgrade
|
| Income Tax Expense | - | - | 665.17 | -282.01 | 188.09 | 144.2 | Upgrade
|
| Net Income | -12,664 | -16,358 | -3,526 | -3,136 | -1,059 | 1,196 | Upgrade
|
| Net Income to Common | -12,664 | -16,358 | -3,526 | -3,136 | -1,059 | 1,196 | Upgrade
|
| Shares Outstanding (Basic) | 19 | 20 | 20 | 20 | 20 | 20 | Upgrade
|
| Shares Outstanding (Diluted) | 19 | 20 | 20 | 20 | 20 | 20 | Upgrade
|
| Shares Change (YoY) | -18.59% | -0.35% | 0.13% | 0.55% | -0.16% | -0.72% | Upgrade
|
| EPS (Basic) | -652.95 | -819.47 | -176.00 | -156.75 | -53.25 | 60.00 | Upgrade
|
| EPS (Diluted) | -652.95 | -819.47 | -176.00 | -156.75 | -53.25 | 60.00 | Upgrade
|
| Free Cash Flow | 2,173 | -125.67 | -6,030 | -2,832 | -765.1 | 641.22 | Upgrade
|
| Free Cash Flow Per Share | 112.05 | -6.30 | -301.02 | -141.57 | -38.45 | 32.18 | Upgrade
|
| Gross Margin | 6.82% | -10.34% | -3.72% | -8.96% | -0.30% | 8.06% | Upgrade
|
| Operating Margin | -4.77% | -20.76% | -10.84% | -18.35% | -7.77% | 1.57% | Upgrade
|
| Profit Margin | -58.66% | -73.13% | -9.66% | -12.38% | -4.31% | 3.18% | Upgrade
|
| Free Cash Flow Margin | 10.07% | -0.56% | -16.52% | -11.18% | -3.12% | 1.70% | Upgrade
|
| EBITDA | 155.19 | -2,167 | -1,189 | -2,083 | 758.6 | 3,971 | Upgrade
|
| EBITDA Margin | 0.72% | -9.69% | -3.26% | -8.22% | 3.09% | 10.56% | Upgrade
|
| D&A For EBITDA | 1,184 | 2,476 | 2,769 | 2,565 | 2,668 | 3,380 | Upgrade
|
| EBIT | -1,029 | -4,643 | -3,958 | -4,648 | -1,909 | 591.1 | Upgrade
|
| EBIT Margin | -4.77% | -20.76% | -10.84% | -18.35% | -7.77% | 1.57% | Upgrade
|
| Effective Tax Rate | - | - | - | - | - | 10.76% | Upgrade
|
| Advertising Expenses | - | 2 | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.